Oesophageal cancer

EC Smyth, J Lagergren, RC Fitzgerald… - Nature reviews Disease …, 2017 - nature.com
Oesophageal cancer is the sixth most common cause of cancer-related death worldwide
and is therefore a major global health challenge. The two major subtypes of oesophageal …

AGA clinical practice update on endoscopic treatment of Barrett's esophagus with dysplasia and/or early cancer: expert review

P Sharma, NJ Shaheen, D Katzka, JJ Bergman - Gastroenterology, 2020 - Elsevier
Description The purpose of this best practice advice article is to describe the role of Barrett's
endoscopic therapy (BET) in patients with Barrett's esophagus (BE) with dysplasia and/or …

[HTML][HTML] Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) guideline

BLAM Weusten, R Bisschops, M Dinis-Ribeiro… - …, 2023 - thieme-connect.com
MR1 ESGE recommends the following standards for Barrett esophagus (BE) surveillance:–a
minimum of 1-minute inspection time per cm of BE length during a surveillance endoscopy …

Barrett esophagus: a review

P Sharma - Jama, 2022 - jamanetwork.com
Importance Barrett esophagus is characterized by the replacement of normal esophageal
squamous cell epithelium with columnar metaplasia and affects approximately 5% of people …

The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled trial

C Bureau, D Thabut, C Jezequel… - Annals of Internal …, 2021 - acpjournals.org
Background: The efficacy of rifaximin in the secondary prevention of overt hepatic
encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode …

Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation±endoscopic resection: results from the national Dutch database in …

S Van Munster, E Nieuwenhuis, BLAM Weusten… - Gut, 2022 - gut.bmj.com
Objective Radiofrequency ablation (RFA)±endoscopic resection (ER) is the preferred
treatment for early neoplasia in Barrett's oesophagus (BE). We aimed to report short-term …

Endoscopic eradication therapy for patients with Barrett's esophagus–associated dysplasia and intramucosal cancer

S Wani, B Qumseya, S Sultan, D Agrawal… - Gastrointestinal …, 2018 - giejournal.org
Barrett's esophagus (BE) is defined by the replacement of the normal squamous epithelium
of the distal esophagus with metaplastic intestinal-type columnar epithelium. 1-3 BE is an …

EMR/ESD: techniques, complications, and evidence

Y Ahmed, M Othman - Current Gastroenterology Reports, 2020 - Springer
Abstract Purpose of Review To discuss endoscopic resection techniques of early
gastrointestinal malignancy. The review will focus on the indications and outcomes of …

Use of a cytosponge biomarker panel to prioritise endoscopic barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot

ND Pilonis, S Killcoyne, WK Tan, M O'Donovan… - The Lancet …, 2022 - thelancet.com
Background Endoscopic surveillance is recommended for patients with Barrett's
oesophagus because, although the progression risk is low, endoscopic intervention is highly …

S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …

A Madisch, H Koop, S Miehlke, J Leers… - Zeitschrift für …, 2023 - thieme-connect.com
Die gastroösophageale Refluxkrankheit gehört zur häufigsten organischen
Oberbaucherkrankung. Zwar hat eine Klasse von Säurehemmern …